These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 21354356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.
    Impellizzeri D, Bruschetta G, Di Paola R, Ahmad A, Campolo M, Cuzzocrea S, Esposito E, Navarra M.
    Clin Nutr; 2015 Dec; 34(6):1146-54. PubMed ID: 25491246
    [Abstract] [Full Text] [Related]

  • 3. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
    Di Paola R, Esposito E, Mazzon E, Riccardi L, Caminiti R, Dal Toso R, Pressi G, Cuzzocrea S.
    Biochem Pharmacol; 2009 Mar 01; 77(5):845-57. PubMed ID: 19070602
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats.
    Cuzzocrea S, Mazzon E, Serraino I, Dugo L, Centorrino T, Ciccolo A, Sautebin L, Caputi AP.
    Eur J Pharmacol; 2001 Nov 09; 431(1):91-102. PubMed ID: 11716847
    [Abstract] [Full Text] [Related]

  • 7. Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.
    Cordaro M, Impellizzeri D, Gugliandolo E, Siracusa R, Crupi R, Esposito E, Cuzzocrea S.
    Mol Pharmacol; 2016 Nov 09; 90(5):549-561. PubMed ID: 27625036
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis.
    Cuzzocrea S, McDonald MC, Mazzon E, Dugo L, Lepore V, Fonti MT, Ciccolo A, Terranova ML, Caputi AP, Thiemermann C.
    Eur J Pharmacol; 2000 Oct 06; 406(1):127-37. PubMed ID: 11011044
    [Abstract] [Full Text] [Related]

  • 10. Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis.
    Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Riley DP, Salvemini D.
    Eur J Pharmacol; 2001 Nov 30; 432(1):79-89. PubMed ID: 11734191
    [Abstract] [Full Text] [Related]

  • 11. Thalidomide treatment reduces colon injury induced by experimental colitis.
    Mazzon E, Muià C, Di Paola R, Genovese T, De Sarro A, Cuzzocrea S.
    Shock; 2005 Jun 30; 23(6):556-64. PubMed ID: 15897810
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin reduces the development of experimental inflammatory bowel disease.
    Cuzzocrea S, Mazzon E, Di Paola R, Patel NS, Genovese T, Muià C, De Sarro A, Thiemermann C.
    J Pharmacol Exp Ther; 2004 Dec 30; 311(3):1272-80. PubMed ID: 15302898
    [Abstract] [Full Text] [Related]

  • 13. CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation.
    Impellizzeri D, Di Paola R, Esposito E, Mazzon E, Paterniti I, Melani A, Bramanti P, Pedata F, Cuzzocrea S.
    Eur J Pharmacol; 2011 Oct 01; 668(1-2):305-16. PubMed ID: 21756897
    [Abstract] [Full Text] [Related]

  • 14. Arvelexin inhibits colonic inflammation by suppression of NF-κB activation in dextran sulfate sodium-induced mice and TNF-α-induced colonic epithelial cells.
    Cho EJ, Shin JS, Chung KS, Lee YS, Cho YW, Baek NI, Chung HG, Lee KT.
    J Agric Food Chem; 2012 Aug 01; 60(30):7398-407. PubMed ID: 22794033
    [Abstract] [Full Text] [Related]

  • 15. The Antioxidant and Anti-Inflammatory Properties of Anacardium occidentale L. Cashew Nuts in a Mouse Model of Colitis.
    Siracusa R, Fusco R, Peritore AF, Cordaro M, D'Amico R, Genovese T, Gugliandolo E, Crupi R, Smeriglio A, Mandalari G, Cuzzocrea S, Di Paola R, Impellizzeri D.
    Nutrients; 2020 Mar 20; 12(3):. PubMed ID: 32245085
    [Abstract] [Full Text] [Related]

  • 16. Preventive effects of guanosine on intestinal inflammation in 2, 4-dinitrobenzene sulfonic acid (DNBS)-induced colitis in rats.
    Zizzo MG, Caldara G, Bellanca A, Nuzzo D, Di Carlo M, Serio R.
    Inflammopharmacology; 2019 Apr 20; 27(2):349-359. PubMed ID: 29907915
    [Abstract] [Full Text] [Related]

  • 17. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat.
    Cuzzocrea S, Ianaro A, Wayman NS, Mazzon E, Pisano B, Dugo L, Serraino I, Di Paola R, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
    Br J Pharmacol; 2003 Feb 20; 138(4):678-88. PubMed ID: 12598422
    [Abstract] [Full Text] [Related]

  • 18. Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system.
    Matos I, Bento AF, Marcon R, Claudino RF, Calixto JB.
    Mol Immunol; 2013 Jul 20; 54(3-4):482-92. PubMed ID: 23454360
    [Abstract] [Full Text] [Related]

  • 19. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis.
    Ko JK, Lam FY, Cheung AP.
    World J Gastroenterol; 2005 Oct 07; 11(37):5787-94. PubMed ID: 16270386
    [Abstract] [Full Text] [Related]

  • 20. 5-Aminoisoquinolinone reduces colon injury by experimental colitis.
    Cuzzocrea S, Mazzon E, Di Paola R, Genovese T, Patel NS, Muià C, Threadgill MD, De Sarro A, Thiemermann C.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec 07; 370(6):464-73. PubMed ID: 15599708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.